Literature DB >> 21721207

[Therapeutic adherence to oral cancer therapy and interdisciplinary management].

L Achtari Jeanneret1, M P Schneider, S Troxler, O Bugnon, F Lüthi.   

Abstract

Medication adherence is a well-known risk factor in internal medicine. However in oncology this dimension is emerging due to the increasing number of oral formulations. First results in the oral oncology literature suggest that patients' ability to cope with medical prescription decreases with time. This might preclude patients from reaching clinical outcomes. Factors impacting on medication adherence to oral oncology treatments have not been yet extensively described neither strategies to address them and support patient's needs. Oncologists and pharmacists in our University outpatient settings performed a pilot study which aimed at measuring and facilitating adherence to oral oncology treatments and at understanding determinants of patient's adherence. The ultimate purpose of such a patient-centered and interdisciplinary collaboration would be to promote patient self-management and complement the standard medical follow-up.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21721207

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  6 in total

1.  Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.

Authors:  Evelina Cardoso; Chantal Csajka; Marie P Schneider; Nicolas Widmer
Journal:  Clin Pharmacokinet       Date:  2018-01       Impact factor: 6.447

2.  Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.

Authors:  Guru R Valicherla; Kandarp M Dave; Anees A Syed; Mohammed Riyazuddin; Anand P Gupta; Akhilesh Singh; Kalyan Mitra; Dipak Datta; Jiaur R Gayen
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

3.  Study on orally delivered paclitaxel nanocrystals: modification, characterization and activity in the gastrointestinal tract.

Authors:  Runcong Liu; Ya-Nan Chang; Gengmei Xing; Min Li; Yuliang Zhao
Journal:  R Soc Open Sci       Date:  2017-11-08       Impact factor: 2.963

Review 4.  Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends.

Authors:  Muhammad Farhan Sohail; Mubashar Rehman; Hafiz Shoaib Sarwar; Sara Naveed; Omer Salman; Nadeem Irfan Bukhari; Irshad Hussain; Thomas J Webster; Gul Shahnaz
Journal:  Int J Nanomedicine       Date:  2018-06-08

Review 5.  Strategies to improve sorafenib efficacy during image-guided treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Zhuoli Zhang; Vahid Yaghmai
Journal:  Ann Transl Med       Date:  2021-12

6.  Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland.

Authors:  Mélanie Lelubre; Susan Kamal; Noëllie Genre; Jennifer Celio; Séverine Gorgerat; Denise Hugentobler Hampai; Aline Bourdin; Jerôme Berger; Olivier Bugnon; Marie Schneider
Journal:  Biomed Res Int       Date:  2016-01-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.